Analysis of variability in determining intact parathyroid hormone (iPTH) according to the method used to process the sample;Análisis de la variabilidad en la determinación de la hormona paratiroidea intacta (PTH-i) según el método empleado para procesar la muestra

Nefrologia

Volumn 29, Issue 4, 2009, Pages 331-335

  Morales Garcia A I ^a   Gorriz Teruel J L ^a   Plancha Mansanet, M C ^a   Escudero Quesada, V ^a   Pallardo Mateu L M ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Processing conditions samples; PTH stability; Variability

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BLOOD; BLOOD EXAMINATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; STANDARD;

ADULT; FEMALE; HEMATOLOGIC TESTS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE;

EID: 70449717645     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/NEFROLOGIA.2009.29.4.5377.EN.FULL     Document Type: Article

References (45)

1. Mann JFE, Gerstein HC, Pogue J, et al. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial. Ann Intern Med 2001;134:629-36.
2. Sarnak MJ, Levey As. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(4,1):117-31.
3. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol.2001;12(10):2131-8.
4. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15(8):2208-18.
5. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int2005;67(3):1179-87.
6. Kestenbaum B, Sampson JN, Rudser KD, et al. Kesten Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease. J Am Soc Nephrol 2005;16:520-8.
7. Portolés J, Górriz JL, Martínez-Castelao A, et al. Chonic kidney disease mineral and bone disorder management in CKD stage 3-4. MERENA study. Nephrol Dial Transplant 2007;22:vi79 (abstract).
8. Górriz JL, Bover J, Caravaca F, et al. Oserce Multicentre Spanish Study: Vitamin D levels in CKD stages 3-5 predialysis. Nephrol Dial Transplant 2007;22:vi173 (abstract).
9. Sherrard DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure-An evolving disorder. Kidney Int 1993;43:436.
10. Hutchison Aj, Whitehose RW, Boulton HF, et al. Correlation of bone histology with parathyroid hormone, vitamin D3 and radiology in end-stage renal disease. Kidney Int 1993;44:1071.
11. Malluche HH, Ritz E, Hodgson M, et al. Skeletal lesions and calcium metabolism in early renal failure. Proc Eur Dial Transplant Assoc 1975;11:443.
12. Llach F, Massry SG, Singer FR, et al. Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure. A possible cause for secondary hyperparathyroidism. J Clin Endocrinol Metab 1975;41:339.
13. Malluche HH, Ritz E, Lange HP, et al. Bone histology in incipient and advanced renal failure. Kidney Int 1976;9:355.
14. Sherrad DJ, Baylink DJ, Wergedal JE, Maloney NA. Quantitative histological studies on the pathogenesis of uremia bone disease. J Clin Endocrinol Metab 1974;39:119.
15. Fournier A, Oprisiu R, Hottelart C et al. Renal osteodystrophy in dialysis patients: Diagnosis and treatment. Artif Organs 1998;22:530.
16. Coen G, Mazzaferro S, Ballanti P, et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study. Nephrol Dial Transplant 1996;11:813.
17. Wang M, Hercz G, Sherrard DJ, et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995;26:836.
18. Hernández D, Concepción MT, Lorenzo V, et al. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution alter maintenance dialysis. Nephrol Dial Transplant 1994;9:517.
19. Andrés DL, Hercz G, COP JB, et al. Bone histomorphometry of renal osteodystrophy in diabetic patients. J Bone Miner Res 1987;2:525.
20. Malluche HH, Monier-Faugere MC. The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol 1994;4:1631.
21. Faugere MC, Malluche HH. Stainable aluminium and not aluminium content reflects bone histology in dialyzed patients. Kidney Int 1986;30:717.
22. Teitelbaum SL. Renal osteodystrophy. Hum Pathol 1984;15:306.
23. Malluche HH, Langub MC, Monier-Faugere MC. The role of bone biopsy in clinical practice and research. Kidney Int Suppl 1999;73:S20.
24. Malluche HH, Langub MC, Monier-Faugere MC. Pathogenesis and histology of renal osteodystrophy. Osteoporos Int 1997;7(3):S184.
25. Freemont T. Histological diagnosis of renal osteodystrophy. Kidney Int Suppl 1999;73:S26.
26. Hodgson, SF. Skeletal remodelling and renal osteodystrophy. Semin Nephrol 1986;6:42.
27. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995;26:622.
28. Sánchez C, Bajo MA, Selgas R, et al. Parathormone secretion in peritoneal dialysis patients with adynamic bonedisease. Am J Kidney Dis 2000;36:953.
29. Gerakis A, Hutchison AJ, Apostolou T, et al. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transplant 1996;11:2430.
30. Ziolkowska H, Paniczyk-Tomaszewska M, Debinski A, et al. Bone biopsy results and serum bone turnover parameters in uremia children. Acta Paediatr 2000;89:666.
31. Solal ME, Sebert JL, Boudailliez B, et al. Comparison of intact, midregion and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 1991;73:516.
32. Souberbielle JC, Boutten A, Carlier MC et al. Inter-method variability in PTH measurement: Implication for the care of CKD patients. Kidney International 2006;70:345-50.
33. Cantor T, Yang Z, Caraiani N, Llamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: Implication for treatment decisions. Clinical Chemistry 2006;52:1771-6.
34. Ureña Torres P. The need for reliable serum parathyroid hormone measurements. Kidney International 2006;70:240-3.
35. Inaba M, Nakatsuka K, Imanishi Y, et al. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clinical Chemistry 2004;50:385-90.
36. Levin GE, Nisbet JA. Stability of parathyroid hormone-related protein and parathyroid hormone at room temperature. Ann Clin Biochem 1994;31:497-500.
37. Kay S, Walker and John Seth. Stability of parathyroid hormone in blood from renal patients on haemodialysis. Ann Clin Biochem 2000;37:800-1.
38. Omar H, Chamberlin A, Walker V and Wood PJ. Immulite 2000 parathyroid hormone assay: stability of parathyroid hormone in EDTA blood kept at room temperature for 48 h. Ann Clin Biochem 2001;38:561-3.
39. Glendenning P, Leonie LA , Hayley K et al. Parathyroid hormone is more stable in EDTA plasma than in serum. Clinical Chemistry 2002;48:766-7.
40. Teal TK, Reed M, Stevens PE and Lamb EJ. Stability of parathyroid hormone ex vivo in haemodialysis patients. Ann Clin Biochem 2003;40:191-3.
41. English E, McFarlane I, Taylor KP, Halsall DJ. The effect of potassium EDTA on the stability of parathyroid hormone in whole blood. Ann Clin Biochem 2007;44:297-9.
42. Cavalier E, Delanaye P, Carlisi A et al. Stability of intact parathyroid hormone in samples from haemodialysis patients. Kidney International 2007;72:370-2.
43. Wood PJ. The measurement of parathyroid hormone. Ann Clin Biochem 1992;29:11-21.
44. Russell D and Henley R. The stability of parathyroid hormone in blood and serum samples at 4 °C and at room temperature. Ann Clin Biochem 1995;32:216-7.
45. Newman PJ and Ashby JP. Clinical and laboratory evaluation of a two-site immunoradiometric assay for intact PTH. Ann Clin Biochem 1988;25:654-60.